Bifidobacteria and preparations containing them
AssigneeAlfa Wassermann S.p.A.
InventorsClaudio Giuseppe Viscomi, Leone Gabriele Rotini, Lorenzo Morelli, Patrizio Ferrari, Maria Rosaria Pantaleo
Life of this patent
Estimating the term…
Abstract
The disclosure refers to biologically pure cultures of two strains of Bifidobacterium Longum named W11 and W11a and deposited at the Belgian Coordinated Collections of Microorganisms (BCCM) that has registered them under the accession numbers LMG P-21586 and LMG P-21587. They are used as probiotics within preparations of pharmaceutical or alimentary products to help the gastrointestinal health and to prevent and treat the intestinal pathologies.
Claims14
A biologically pure culture of a strain Bifidobacterium Longum LMG P-21586.
A biologically pure culture of a strain Bifidobacterium Longum LMG P-21587.
A pharmaceutical or alimentary preparation containing between 1×107 and 1×1011 colony forming units of live cells of a biologically pure culture of a strain Bifidobacterium Longum LMG P-21586.
A pharmaceutical or alimentary preparation containing between 1×107 and 1×1011 colony forming units of live cells of a biologically pure culture of a strain Bifidobacterium Longum LMG P-21587.
Dependencies are inferred from the claim text.